Longman L P, Martin M V, Smalley J W
School of Dental Surgery, University of Liverpool, U.K.
J Antimicrob Chemother. 1987 Oct;20(4):557-62. doi: 10.1093/jac/20.4.557.
The efficacy of cephradine in the prophylaxis of rabbit Streptococcus sanguis endocarditis was investigated. Three days after cardiac catheterization and prior to challenge with S. sanguis, rabbits received either 1000 mg/kg (ten animals) or 500 mg/kg cephradine intramuscularly. Infective endocarditis was prevented in only 30% of the animals. The addition of a second dose of cephradine (100 mg/kg) 8 h after an initial dose of 400 mg/kg did not prevent streptococcal endocarditis in 80% of animals tested. In one or two dose regimens cephradine was found to be inferior to a single 400 mg/kg prophylactic dose of amoxycillin. Cephradine is not recommended for prophylaxis against streptococcal endocarditis.
研究了头孢拉定预防兔血链球菌性心内膜炎的疗效。在进行心脏导管插入术后三天,且在接受血链球菌攻击之前,兔子分别接受了1000mg/kg(十只动物)或500mg/kg头孢拉定的肌肉注射。仅30%的动物预防了感染性心内膜炎。在初始剂量400mg/kg后8小时添加第二剂头孢拉定(100mg/kg),在80%的受试动物中未能预防链球菌性心内膜炎。在单剂量或两剂量方案中,发现头孢拉定不如单次400mg/kg预防性剂量的阿莫西林。不推荐使用头孢拉定预防链球菌性心内膜炎。